cas 957208-65-0|| where to buy 4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene

Nom du produit:4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene

IUPAC Name:4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene

Unité d'emballage	Stock disponible	Prix($)
CM388073-1g	in stock	ŵƛ
CM388073-5g	in stock	ƿƥǜ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 957208-65-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:957208-65-0; Formule moléculaire:C13H14ClF3; Point de fusion:-; Code SMILES:FC(F)(F)C1=CC(CCl)=CC=C1C1CCCC1; Densité:

: Numéro de catalogue:CM388073; Poids moléculaire:262.7; Point d'ébullition:; N° Mdl:; Stockage:

: Cyclopentanes; Cyclopentane is a cycloalkane, an organic compound with a molecular formula of C5H10, a colorless and transparent liquid, insoluble in water, soluble in most organic solvents such as ethanol, ether, benzene, carbon tetrachloride, acetone, etc. It is mainly used as a solvent and chromatographic reference materials.; Cyclopentanes,where to buy Cyclopentanes; Cyclopentanes; Cyclopentane (also called C pentane) is a highly flammable alicyclic hydrocarbon with chemical formula C5H10 and CAS number 287-92-3, consisting of a ring of five carbon atoms each bonded with two hydrogen atoms above and below the plane. It occurs as a colorless liquid with a petrol-like odor.

: Etrasimod; Etrasimod is a new generation of oral S1P receptor modulator, which can specifically bind to S1P receptors 1, 4, and 5. It is being studied for a range of immune inflammatory diseases, including ulcerative colitis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. At present, the highest stage of research and development of the drug is to apply for marketing, which is used to treat ulcerative colitis and is expected to be approved by FDA in this month.